Cortical Shape and Curvedness Analysis of Structural Deficits in Remitting and Non-Remitting Depression

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Liao, Yuan Lin ^a   Wang, Po Shan ^a,b,c   Lu, Chia Feng ^a,d   Hung, Chih I ^a   Li, Cheng Ta ^a,c   Lin, Ching Po ^a   Hsieh, Jen Chuen ^a,c,e   Su, Tung Ping ^a,c   Wu, Yu Te ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MUNICIPAL GAN DAU HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e National Health and Research Institute   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DOPAMINE UPTAKE INHIBITOR; NORADRENALIN DOPAMINE REUPTAKE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL CURVEDNESS; CORTICAL SHAPE; DRUG TREATMENT FAILURE; FEMALE; HIPPOCAMPUS; HUMAN; INFERIOR FRONTAL GYRUS; MAJOR DEPRESSION; MALE; MIDDLE FRONTAL GYRUS; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; REMISSION; SEROTONINERGIC SYSTEM; VOXEL BASED MORPHOMETRY;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; SEROTONIN; YOUNG ADULT;

EID: 84880480214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068625     Document Type: Article

References (46)

1. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, et al. (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21: 655-679.
2. Hamilton M, (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
3. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, et al. (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48: 851-855.
4. Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, et al. (2009) What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 60: 1439-1445.
5. Li C-T, Bai Y-M, Huang Y-L, Chen Y-S, Chen T-J, et al. (2012) Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study. Br J Psychiatry 200: 45-51.
6. Herrera-Guzmán I, Herrera-Abarca JE, Gudayol-Ferré E, Herrera-Guzmán D, Gómez-Carbajal L, et al. (2010) Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatry Res 177: 323-329.
7. Miller JM, Oquendo MA, Ogden RT, Mann JJ, Parsey RV, (2008) Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. J Psychiatr Res 42: 1137-1144.
8. Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC, (2007) Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiatry 62: 1217-1227.
9. Murrough JW, Iacoviello B, Neumeister A, Charney DS, Iosifescu DV, (2011) Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem 96: 553-563.
10. Diener C, Kuehner C, Brusniak W, Ubl B, Wessa M, et al. (2012) A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. Neuroimage 61: 677-685.
11. Bora E, Harrison BJ, Davey CG, Yücel M, Pantelis C, (2012) Meta-analysis of volumetric abnormalities in cortico-striatal-pallidal-thalamic circuits in major depressive disorder. Psychol Med 42: 671-681.
12. Malykhin NV, Carter R, Hegadoren KM, Seres P, Coupland NJ, (2012) Fronto-limbic volumetric changes in major depressive disorder. J Affect Disord 136: 1104-1113.
13. Zhang Y, Yu C, Zhou Y, Li K, Li C, et al. (2009) Decreased gyrification in major depressive disorder. Neuroreport 20: 378-380.
14. Tu P-C, Chen L-F, Hsieh J-C, Bai Y-M, Li C-T, et al. (2012) Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study. Psychiatry Res 202: 206-213.
15. Penttilä J, Cachia A, Martinot J-L, Ringuenet D, Wessa M, et al. (2009) Cortical folding difference between patients with early-onset and patients with intermediate-onset bipolar disorder. Bipolar Disord 11: 361-370.
16. Wu Y-T, Shyu K-K, Jao C-W, Liao Y-L, Wang T-Y, et al. (2012) Quantifying cerebellar atrophy in multiple system atrophy of the cerebellar type (MSA-C) using three-dimensional gyrification index analysis. Neuroimage 61: 1-9.
17. Wu Y-T, Shyu K-K, Jao C-W, Wang Z-Y, Soong B-W, et al. (2010) Fractal dimension analysis for quantifying cerebellar morphological change of multiple system atrophy of the cerebellar type (MSA-C). Neuroimage 49: 539-551.
18. Ronan L, Pienaar R, Williams G, Bullmore E, Crow TJ, et al. (2011) Intrinsic curvature: a marker of millimeter-scale tangential cortico-cortical connectivity? Int J Neural Syst 21: 351-366.
19. Awate SP, Yushkevich PA, Song Z, Licht DJ, Gee JC, (2010) Cerebral cortical folding analysis with multivariate modeling and testing: studies on gender differences and neonatal development. Neuroimage 53: 450-459.
20. Hu H-H, Chen H-Y, Hung C-I, Guo W-Y, Wu Y-T (2012) Shape and curvedness analysis of brain morphology using human fetal magnetic resonance images in utero. Brain Struct Funct: In press.
21. Chen C-H, Ridler K, Suckling J, Williams S, Fu CHY, et al. (2007) Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 62: 407-414.
22. Phillips JL, Batten LA, Aldosary F, Tremblay P, Blier P, (2012) Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. J Clin Psychiatry 73: 625-631.
23. Sheline YI, Disabato BM, Hranilovich J, Morris C, D'Angelo G, et al. (2012) Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry.
24. Arnone D, McKie S, Elliott R, Juhasz G, Thomas EJ, et al. (2012) State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry.
25. Liu F, Guo W, Yu D, Gao Q, Gao K, et al. (2012) Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans. PLoS ONE 7: e40968.
26. Li C-T, Lin C-P, Chou K-H, Chen IY, Hsieh J-C, et al. (2010) Structural and cognitive deficits in remitting and non-remitting recurrent depression: A voxel-based morphometric study. Neuroimage 50: 347-356.
27. Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, et al. (2011) Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage 54: 2643-2651.
28. Caetano SC, Hatch JP, Brambilla P, Sassi RB, Nicoletti M, et al. (2004) Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res 132: 141-147.
29. Dunner DL (2008) Major Depressive Disorder. In: Fatemi SH, Clayton P, editors. The Medical Basis of Psychiatry: Humana Press. 73-83.
30. Maalouf FT, Atwi M, Brent DA, (2011) Treatment-resistant depression in adolescents: review and updates on clinical management. Depress Anxiety 28: 946-954.
31. Ardekani BA, Bachman AH, (2009) Model-based automatic detection of the anterior and posterior commissures on MRI scans. Neuroimage 46: 677-682.
32. Ségonne F, Dale AM, Busa E, Glessner M, Salat D, et al. (2004) A hybrid approach to the skull stripping problem in MRI. Neuroimage 22: 1060-1075.
33. Sled JG, Zijdenbos AP, Evans AC, (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17: 87-97.
34. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, et al. (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273-289.
35. Alemán-Gómez Y, Melie-García L, Valdés-Hernandez P (2006) IBASPM: Toolbox for automatic parcellation of brain structures. The 12th Annual Meeting of the Organization for Human Brain Mapping. Florence, Italy.
36. Crespo-Facorro B, Roiz-Santiáñez R, Pérez-Iglesias R, Mata I, Rodríguez-Sánchez JM, et al. (2011) Sex-specific variation of MRI-based cortical morphometry in adult healthy volunteers: the effect on cognitive functioning. Prog Neuropsychopharmacol Biol Psychiatry 35: 616-623.
37. Janssen J, Reig S, Alemán Y, Schnack H, Udias JM, et al. (2009) Gyral and sulcal cortical thinning in adolescents with first episode early-onset psychosis. Biol Psychiatry 66: 1047-1054.
38. Prasad KM, Goradia D, Eack S, Rajagopalan M, Nutche J, et al. (2010) Cortical surface characteristics among offspring of schizophrenia subjects. Schizophr Res 116: 143-151.
39. Thirion J-P, Gourdon A, (1995) Computing the differential characteristics of isointensity surfaces. Comput Vis Image Underst 61: 190-202.
40. Wagner G, Koch K, Schachtzabel C, Reichenbach JR, Sauer H, et al. (2008) Enhanced rostral anterior cingulate cortex activation during cognitive control is related to orbitofrontal volume reduction in unipolar depression. J Psychiatry Neurosci 33: 199-208.
41. Du M-Y, Wu Q-Z, Yue Q, Li J, Liao Y, et al. (2012) Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 36: 11-16.
42. Lim HK, Jung WS, Ahn KJ, Won WY, Hahn C, et al. (2012) Regional cortical thickness and subcortical volume changes are associated with cognitive impairments in the drug-naive patients with late-onset depression. Neuropsychopharmacology 37: 838-849.
43. Owens MJ, Nemeroff CB, (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40: 288-295.
44. Parsey RV, Olvet DM, Oquendo MA, Huang Y-y, Ogden RT, et al. (2006) Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31: 1745-1749.
45. Miller JM, Brennan KG, Ogden TR, Oquendo MA, Sullivan GM, et al. (2009) Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology 34: 2275-2284.
46. Höflich A, Baldinger P, Savli M, Lanzenberger R, Kasper S, (2012) Imaging treatment effects in depression. Rev Neurosci 23: 227-252.